Further mechanistic study on the effect of compound 2 on A549 cancer cells revealed that a treatment with 2 inhibited the transforming growth factor-β (TGF-β)-induced EMT in A549 human lung cancer cells by modulating Smad-dependent signaling. This evidence concerns the gene TGFB1 and cancer.